Announcement of amendment of the Company's 2021 Annual Report
· Issued by OBI Pharma, Inc.
Close
Today's Information
Provided by: OBI Pharma, Inc.
SEQ_NO
1
Date of announcement
2022/08/11
Time of announcement
14:48:39
Subject
Announcement of amendment of the Company's 2021
Annual Report
Date of events
2022/08/11
To which item it meets
paragraph 50
Statement
1.Date of receipt of letter from TPEx to request
supplement or correction:2022/08/09
2.Deadline imposed for supplement or correction:2022/08/11
3.Content of supplement or correction:Pursuant to the instruction of Taipei
Exchange, the Company amend p4~6 and p12~13 of its Chinese version of
2021 Annual Report; p6~p8 and p20~22 of its English version of 2021 Annual
Report.
4.Countermeasures:Re-uploaded the Annual Report(Revised after the
Shareholder's Meeting) to MOPS.
5.Any other matters that need to be specified:None
